Balance Sheet Data

Horizon Therapeutics Public Limited... (HZNP)

$96.3

-0.55 (-0.57%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 757.86966.921,088.992,098.331,606.843,303.774,442.505,973.748,032.7610,801.47
Total Cash (%)
Account Receivables 367.35464.73408.69659.70632.781,338.801,800.262,420.763,255.154,377.13
Account Receivables (%)
Inventories 73.0755.2953.8075.28225.73226.06303.98408.75549.64739.09
Inventories (%)
Accounts Payable 34.6830.2821.5137.7130.1287.58117.77158.36212.95286.35
Accounts Payable (%)
Capital Expenditure -4.33-16.77-17.86-199.85-126.17-140.27-188.62-253.63-341.05-458.60
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.